Semaglutide (Wegovy or Ozempic) and Trizepatide (Mounjaro or Zepbound) are two new medications that can aid in weight loss. Semaglutide and Tirzepatide are administered once a week through injection. There is also an oral dosage form for Semaglutide. Both Semaglutide and Tirzepatide are GLP-1 agonists (Incretins). They work by signaling to your brain that you are full, which helps you eat less. Additionally, Semaglutide and Tirzepatide slow down the movement of food through your stomach, allowing you to feel full for longer periods of time. Semaglutide has been around longer than Trizepatide, with better usage safety data and more popular. Tirzepatide is more expensive as its newer to the market than Semaglutide. Our medical weight loss program uses Semaglutide mostly, which is specially designed to help individuals lose weight, boost energy levels, and regain vitality.
MD-Guided medical weight loss program utilizing Semaglutide & Tirzepatide to assist patients lose an average of up to 1-3 pounds per week.